Veterans Cannabis Analysis, Research, and Effectiveness Act
The Veterans Cannabis Analysis, Research, and Effectiveness (CARE) Act was introduced in the 117th U.S. Congress in 2021 as H.R. 2932 and in the 118th Congress as H.R. 3584 in 2023.
The bill requires the Department of Veterans Affairs (VA) to conduct and support research on the efficacy and safety of certain forms of cannabis and cannabis delivery for veterans enrolled in the VA health care system and diagnosed with conditions such as chronic pain or post-traumatic stress disorder.
The 2021 bill was advanced to committees but did not reach the floor.[1] The latter bill was announced in April,[2] and introduced by Representative Mariannette Miller-Meeks, a Republican, in May, 2023,[3] and the United States House Veterans' Affairs Subcommittee on Health held hearings on the bill on March 21, 2024.[4] At the hearings, the VA supported the bill with amendments.[5]
References
[edit]- ^ Melissa Kuipers Blake; Osiris Morel (January 25, 2022), Cannabis Legislation Wrap Up For 2021, Mondaq
- ^ "Miller-Meeks & Mace Introduce Legislation to Support Medical Cannabis Research for Veterans". house.gov official website (press release). Office of Representative Mariannette Miller-Meeks. April 30, 2021.
- ^ Zdinjak, Nina (August 4, 2023). "Don't Our Veterans Deserve Better Than Opioids? Updated Directive Still Says No To Medical Marijuana". Benzinga.
- ^ https://veterans.house.gov/calendar/eventsingle.aspx?EventID=6394
- ^ Goldstein, Lara (March 22, 2024). "VA Calls For Amending Medical Marijuana Bill, Rejects Psychedelics Proposal". Benzinga.
External links
[edit]- H.R. 3584 at congress.gov
This article incorporates public domain material from Summary of H.R. 3584: Veterans CARE Act. Congressional Research Service.
